Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2010 and based in Paris, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancer. Invectys exploits a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys focuses its efforts on the universal tumor antigen telomerase that is critical to...
Founded in 2010 and based in Paris, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancer. Invectys exploits a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys focuses its efforts on the universal tumor antigen telomerase that is critical to uncontrolled cell growth.

List your booth number for exhibitions, ask us